MCQ NO. 626 | Pharmacology
Select the drug which exhibits dual alpha and beta adrenergic receptor agonists activity.
Select the drug which exhibits dual alpha and beta adrenergic receptor agonists activity.
Anonymous Quiz
18%
Terbutaline
26%
Clonidine
27%
Metaproterenol
29%
Dobutamine
MCQ NO.627 | Pharmacology
Acute attack of Asthma treated with?
Acute attack of Asthma treated with?
Anonymous Quiz
60%
Bronchodilators
10%
Steroids
19%
Mast cell stabilisation
11%
Anti cholinergics
MCQ NO.628 | Pharmacology
Drugs contraindicate in Asthma patient?
Drugs contraindicate in Asthma patient?
Anonymous Quiz
14%
Morphine
14%
Aspirin
20%
Propranolol
53%
All
MCQ NO.629 | Pharmacology
Anti IgE used in Asthma?
Anti IgE used in Asthma?
Anonymous Quiz
29%
Montelukast
22%
Zafrilukast
12%
Zeluton
36%
Omalizuman
MCQ NO.630 | Pharmacology
Drug used to stabilize Mast Cell?
Drug used to stabilize Mast Cell?
Anonymous Quiz
37%
Chromolyn sodium
10%
Terbutaline
9%
Ipratropium
43%
All
Years Of Different Act :
1. Opium Act -1875
2. Poisonous Act -1919
3. Dangerous Drug Act -1930
4. Drug & Cosmetic Act Act – 1940 & Rule – 1945
5. Factory Act - 1949
6. Pharmacy Act -1948
7. Pharmacy Council Of
India {PCI} -1949
8. Drug & Magic Remedies - 1954
9. Medical & Toilet
Preparation Act – 1955 & Rule – 1956.
10. Patent Act -1970
11. Medicinal Termination &
Pregnancy Act - 1971
12. GMP - 1975
13. Narcotic & Psychotropic
Act -1985
14. Drug Price Control Order - 1955
15. The All India Council For
Technical Education Act
-1994
16. First ICH Indian Pharmacopoeia -1989
17. 1 st Edition IP - 1955
18. 2 nd Edition IP -1966
19. 3 rd Edition IP -1985
20. 4 th Edition IP -1996
21. 5th Edition IP - 2007
22. 6th Edition IP - 2010
23. 7th Edition IP - 2014
24. 8th Edition IP - 2018
1. Opium Act -1875
2. Poisonous Act -1919
3. Dangerous Drug Act -1930
4. Drug & Cosmetic Act Act – 1940 & Rule – 1945
5. Factory Act - 1949
6. Pharmacy Act -1948
7. Pharmacy Council Of
India {PCI} -1949
8. Drug & Magic Remedies - 1954
9. Medical & Toilet
Preparation Act – 1955 & Rule – 1956.
10. Patent Act -1970
11. Medicinal Termination &
Pregnancy Act - 1971
12. GMP - 1975
13. Narcotic & Psychotropic
Act -1985
14. Drug Price Control Order - 1955
15. The All India Council For
Technical Education Act
-1994
16. First ICH Indian Pharmacopoeia -1989
17. 1 st Edition IP - 1955
18. 2 nd Edition IP -1966
19. 3 rd Edition IP -1985
20. 4 th Edition IP -1996
21. 5th Edition IP - 2007
22. 6th Edition IP - 2010
23. 7th Edition IP - 2014
24. 8th Edition IP - 2018
Immunoglobulins: Important Points To Remember
1. Smallest Ig- IgG
2. Largest Ig- IgM
3. Maximum serum concentration- IgG
4. Minimum serum concentration- IgE
5.Heat Labile- IgE
6. Earliest to be Synthesised (primary immune response)- IgM
7. Secondary immune response- IgG
8. Crosses Placenta- IgG
9. Minimum half Life- IgE
10. Maximum half life- IgG
11. Protects Surfaces- IgA
12. Warm Antibodies- IgG
13. Cold Antbodies- IgM
14. Present in Milk- IgG and IgA
15. Fix complements via classical pathway- IgM & IgG
16. Fix complements via alternative pathway- IgA & IgD
17. Primary allergic response- IgE
18. Maximum sedimentation cofficient- IgM
19. Reagin activity - IgE
20. Antigen recognition by B cells - IgD
21. Prausnitz kustner reaction - IgE
22. Homocytotropism - IgE
23. Present in milk - IgA & IgG
24. Highest carbohydrate - IgE
25. Lowest carbohydrate - IgG
1. Smallest Ig- IgG
2. Largest Ig- IgM
3. Maximum serum concentration- IgG
4. Minimum serum concentration- IgE
5.Heat Labile- IgE
6. Earliest to be Synthesised (primary immune response)- IgM
7. Secondary immune response- IgG
8. Crosses Placenta- IgG
9. Minimum half Life- IgE
10. Maximum half life- IgG
11. Protects Surfaces- IgA
12. Warm Antibodies- IgG
13. Cold Antbodies- IgM
14. Present in Milk- IgG and IgA
15. Fix complements via classical pathway- IgM & IgG
16. Fix complements via alternative pathway- IgA & IgD
17. Primary allergic response- IgE
18. Maximum sedimentation cofficient- IgM
19. Reagin activity - IgE
20. Antigen recognition by B cells - IgD
21. Prausnitz kustner reaction - IgE
22. Homocytotropism - IgE
23. Present in milk - IgA & IgG
24. Highest carbohydrate - IgE
25. Lowest carbohydrate - IgG
MCQ NO 631 | Sub- pharmacology
Somatostatin is produced in the pancreas from γ-cells and acts as
Somatostatin is produced in the pancreas from γ-cells and acts as
Anonymous Quiz
9%
(a) Stimulates release of insulin
35%
(b) Stimulate release of insulin and glucagon
45%
(c) Inhibits release of insulin and glucagon
11%
(d) Stimulate release of glucagon
MCQ NO 632 | Pharmacognosy
Select the drug , which is not showing carminative property ?
Select the drug , which is not showing carminative property ?
Anonymous Quiz
23%
A. Dill
25%
B. mentha
37%
C. Senna
16%
D. Cardamom
MCQ NO. 633 | Industrial Pharmacy
Opadry means....
Opadry means....
Anonymous Quiz
19%
A. Opaquant color concentrate for sugar coating
32%
B. Opaque color concentrate for film coating
12%
C. Complete film coating concentrate
38%
D. Both A & B
MCQ NO 634 | Pharmaceutical Jurisprudence
List of coalter colour permitted to be used in cosmetics come under the schedule
List of coalter colour permitted to be used in cosmetics come under the schedule
Anonymous Quiz
10%
A. J
22%
B. K
11%
C. N
57%
D. Q
MCQ NO 635 | Medicinal Chemistryl
What is the site of action of diuretic mannitol?
What is the site of action of diuretic mannitol?
Anonymous Quiz
31%
A.Proximal tubules
16%
B.Glomerulus
34%
C.Descending loop
18%
D.Distal tubules
MCQ NO 636 | Biochemistry
In the preparation of small pox vaccine, the drying process used is...
In the preparation of small pox vaccine, the drying process used is...
Anonymous Quiz
61%
A. Freeze drying
8%
B. drum drying
16%
C. spray drying
15%
D. Vacuum drying
MCQ No.637 | Biotechnology
____no’s of template molecules can be amplified after 20 cycles of PCR
____no’s of template molecules can be amplified after 20 cycles of PCR
Anonymous Quiz
35%
A. 108
24%
B. 109
17%
C. 107
24%
D. 106
MCQ NO 638 | Pharmacology
Quinolones side effects are -
Quinolones side effects are -
Anonymous Quiz
12%
A- photosensitivity
11%
B- vommeting
15%
C- CNS side effect
62%
D- both a & c
MCQ NO 639 | pharmaceutics
The ability of a substance to exist as two or more crystalline phases with different arrangements of molecules in crystal lattice is
The ability of a substance to exist as two or more crystalline phases with different arrangements of molecules in crystal lattice is
Anonymous Quiz
9%
A. Cocrystal
11%
B. Crystal
76%
C. Polymorphism
4%
D. None of the above
MCQ NO 640 | pharmaceutics
Which is not an antioxidant
Which is not an antioxidant
Anonymous Quiz
19%
A. Sodium sulphite
29%
B. Sodium metabisulphite
34%
C. Sodium sulphate
18%
D. Sodium thiosulphate
🔴Competitive antagonism 🔴
📌Reversible competitive antagonism is the commonest and most important type of antagonism ; it has two main characteristics:
–in the presence of the antagonist, the agonist log concentration–effect curve is shifted to the right without change in slope or maximum, the extent of the shift being a measure of thedose ratio
–the dose ratio increases linearly with antagonist concentration
📌•Antagonist affinity, measured in this way, is widely used as a basis for receptor classification.
📌Reversible competitive antagonism is the commonest and most important type of antagonism ; it has two main characteristics:
–in the presence of the antagonist, the agonist log concentration–effect curve is shifted to the right without change in slope or maximum, the extent of the shift being a measure of thedose ratio
–the dose ratio increases linearly with antagonist concentration
📌•Antagonist affinity, measured in this way, is widely used as a basis for receptor classification.
🔴Agonists, antagonists and efficacy🔴
📌•Drugs acting on receptors may be agonists or antagonists.
📌•Agonists initiate changes in cell function, producing effects of various types; antagonists bind to receptors without initiating such changes.
📌•Agonist potency depends on two parameters: affinity (i.e.tendency to bind to receptors) and efficacy (i.e. ability, once bound, to initiate changes that lead to effects).
📌•For antagonists, efficacy is zero.
📌•Full agonists (which can produce maximal effects) have high efficacy; partial agonists (which can produce only submaximal effects) have intermediate efficacy.
📌•According to the two-state model, efficacy reflects the relative affinity of the compound for the resting and activated states of the receptor. Agonists show selectivity for the activated state; antagonists show no selectivity. This model, although helpful, fails to account for the complexity of agonist action. •Inverse agonists show selectivity for the resting state of the receptor, this being of significance only in situations where the receptors show constitutive activity.
📌•Allosteric modulators bind to sites on the receptor other than the agonist binding site and can modify agonist activity.
📌•Drugs acting on receptors may be agonists or antagonists.
📌•Agonists initiate changes in cell function, producing effects of various types; antagonists bind to receptors without initiating such changes.
📌•Agonist potency depends on two parameters: affinity (i.e.tendency to bind to receptors) and efficacy (i.e. ability, once bound, to initiate changes that lead to effects).
📌•For antagonists, efficacy is zero.
📌•Full agonists (which can produce maximal effects) have high efficacy; partial agonists (which can produce only submaximal effects) have intermediate efficacy.
📌•According to the two-state model, efficacy reflects the relative affinity of the compound for the resting and activated states of the receptor. Agonists show selectivity for the activated state; antagonists show no selectivity. This model, although helpful, fails to account for the complexity of agonist action. •Inverse agonists show selectivity for the resting state of the receptor, this being of significance only in situations where the receptors show constitutive activity.
📌•Allosteric modulators bind to sites on the receptor other than the agonist binding site and can modify agonist activity.
🔴Types of drug antagonism🔴
Drug antagonism occurs by various mechanisms:
📌 •Chemical antagonism (interaction in solution)
📌 •Pharmacokinetic antagonism (one drug affecting the absorption, metabolism or excretion of the other)
📌 •Competitive antagonism (both drugs binding to the same receptors) ; the antagonism may be reversible or irreversible
📌•Interruption of receptor–response linkage
📌•Physiological antagonism (two agents producing opposing physiological effects).
Drug antagonism occurs by various mechanisms:
📌 •Chemical antagonism (interaction in solution)
📌 •Pharmacokinetic antagonism (one drug affecting the absorption, metabolism or excretion of the other)
📌 •Competitive antagonism (both drugs binding to the same receptors) ; the antagonism may be reversible or irreversible
📌•Interruption of receptor–response linkage
📌•Physiological antagonism (two agents producing opposing physiological effects).